Nalaganje...
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells
PURPOSE: Polo-like kinase 4 (PLK4) inhibitors, such as CFI-400945 and centrinone, are emerging as promising antineoplastic agents. However, their effectiveness against Ewing’s sarcoma, a highly aggressive childhood cancer, remains to be established. METHODS: CFI-400945 and centrinone were tested in...
Shranjeno v:
| izdano v: | J Cancer Res Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519924/ https://ncbi.nlm.nih.gov/pubmed/32770382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-020-03346-z |
| Oznake: |
Označite
Brez oznak, prvi označite!
|